ProTargetMiner as a proteome signature library of anticancer molecules for functional discovery
Anticancer drugs often have widespread effects on the cellular proteome. Here, the authors generate a proteome signature library of drug-treated cancer cell lines and develop a software tool to deconvolute drug targets and gain insights into their mechanisms of action.
Main Authors: | Amir Ata Saei, Christian Michel Beusch, Alexey Chernobrovkin, Pierre Sabatier, Bo Zhang, Ülkü Güler Tokat, Eleni Stergiou, Massimiliano Gaetani, Ákos Végvári, Roman A. Zubarev |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-13582-8 |
Similar Items
-
System-wide identification and prioritization of enzyme substrates by thermal analysis
by: Amir Ata Saei, et al.
Published: (2021-02-01) -
Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins.
by: Alexey L Chernobrovkin, et al.
Published: (2014-01-01) -
Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin
by: Amir Ata Saei, et al.
Published: (2020-05-01) -
Advances in Anticancer Drug Discovery
by: Jóhannes Reynisson
Published: (2021-03-01) -
Discovery of Urinary Proteomic Signature for Differential Diagnosis of Acute Appendicitis
by: Yinghua Zhao, et al.
Published: (2020-01-01)